Rapid Micro Biosystems, Inc. (RPID): Price and Financial Metrics
RPID Price/Volume Stats
| Current price | $1.09 | 52-week high | $3.72 |
| Prev. close | $1.08 | 52-week low | $0.83 |
| Day low | $1.07 | Volume | 5,355 |
| Day high | $1.10 | Avg. volume | 55,889 |
| 50-day MA | $1.00 | Dividend yield | N/A |
| 200-day MA | $1.12 | Market Cap | 46.14M |
RPID Stock Price Chart Interactive Chart >
RPID Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for RPID is 0.14 -- better than only 14.66% of US stocks.
- RPID's went public 2.2 years ago, making it older than only 5.14% of listed US stocks we're tracking.
- RPID's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 10.88% of US stocks.
- If you're looking for stocks that are quantitatively similar to RAPID MICRO BIOSYSTEMS INC, a group of peers worth examining would be CVV, LAB, APDN, SHPW, and OSUR.
- To check out RAPID MICRO BIOSYSTEMS INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001380106.
RPID Valuation Summary
- In comparison to the median Healthcare stock, RPID's price/sales ratio is 37.5% lower, now standing at 2.5.
- RPID's EV/EBIT ratio has moved up 21.8 over the prior 27 months.
Below are key valuation metrics over time for RPID.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RPID | 2023-09-22 | 2.5 | 0.3 | -0.8 | -0.4 |
| RPID | 2023-09-21 | 2.5 | 0.3 | -0.8 | -0.4 |
| RPID | 2023-09-20 | 2.5 | 0.3 | -0.8 | -0.4 |
| RPID | 2023-09-19 | 2.5 | 0.3 | -0.8 | -0.4 |
| RPID | 2023-09-18 | 2.5 | 0.3 | -0.8 | -0.4 |
| RPID | 2023-09-15 | 2.6 | 0.4 | -0.8 | -0.4 |
RPID Price Target
For more insight on analysts targets of RPID, see our RPID price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $28.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Rapid Micro Biosystems, Inc. (RPID) Company Bio
Rapid Micro Biosystems, Inc. provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers Growth Direct system that includes an automated imaging instrument that analyzes user-prepared proprietary consumables. The company also provides on-site installation, instrument, validation services, regulatory compliance assistance, system certification training and training re-freshers, and business case preparation and return-on-investment analysis services; and technical support services in the Americas and Europe. It solutions are used in environmental monitoring, water testing, and bioburden testing applications. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is based in Lowell, Massachusetts with an additional office in Freising/Weihenstephan, Germany.
Latest RPID News From Around the Web
Below are the latest news stories about RAPID MICRO BIOSYSTEMS INC that investors may wish to consider to help them evaluate RPID as an investment opportunity.
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its participation as a platinum sponsor and exhibitor at the 2023 Parenteral Drug Association (“PDA”) Pharmaceutical Microbiology Conference from October 2 - 4 in Washington, D.C. This year |
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company ShowcaseLOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the virtual Gilmartin Group Emerging Growth Company Showcase. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are scheduled to participate virtu |
Insider Buying: CFO Sean Wirtjes Acquires 10,000 Shares of Rapid Micro Biosystems IncOn September 6, 2023, Sean Wirtjes, the Chief Financial Officer of Rapid Micro Biosystems Inc (NASDAQ:RPID), made a significant purchase of 10,000 shares of the company's stock. |
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare ConferenceLOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are scheduled to participate in a 3 |
Q2 2023 Rapid Micro Biosystems Inc Earnings CallQ2 2023 Rapid Micro Biosystems Inc Earnings Call |
RPID Price Returns
| 1-mo | N/A |
| 3-mo | 12.49% |
| 6-mo | N/A |
| 1-year | -68.86% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -3.54% |
| 2022 | -89.38% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...